BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 15786373)

  • 1. [New immunodepressant drugs for the prevention and control of kidney transplant rejection].
    Segoloni GP
    G Ital Nefrol; 2005; 22(1):3-15. PubMed ID: 15786373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunossupresive drugs in renal transplantation].
    Baczkowska T; Durlik M
    Pol Arch Med Wewn; 2004 Oct; 112 Spec No():99-120. PubMed ID: 15669207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunosuppressive drugs in paediatric liver transplantation.
    van Mourik ID; Kelly DA
    Paediatr Drugs; 2001; 3(1):43-60. PubMed ID: 11220404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Balancing efficacy and toxicity in kidney-transplant immunosuppression.
    Leichtman AB
    N Engl J Med; 2007 Dec; 357(25):2625-7. PubMed ID: 18094383
    [No Abstract]   [Full Text] [Related]  

  • 5. Current immunosuppressive agents: efficacy, side effects, and utilization.
    Smith JM; Nemeth TL; McDonald RA
    Pediatr Clin North Am; 2003 Dec; 50(6):1283-300. PubMed ID: 14710781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal transplantation: basic concepts and evolution of therapy.
    Braun WE
    J Clin Apher; 2003; 18(3):141-52. PubMed ID: 14569608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of transplant rejection: are the traditional immunosuppressants good enough?
    Dumont FJ
    Curr Opin Investig Drugs; 2001 Mar; 2(3):357-63. PubMed ID: 11575705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New immunosuppressive strategies in renal transplant recipients.
    Fischereder M; Kretzler M
    J Nephrol; 2004; 17(1):9-18. PubMed ID: 15151254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcineurin inhibitor avoidance with daclizumab, mycophenolate mofetil, and prednisolone in DR-matched de novo kidney transplant recipients.
    Asberg A; Midtvedt K; Line PD; Narverud J; Holdaas H; Jenssen T; Reisaeter AV; Johnsen LF; Fauchald P; Hartmann A
    Transplantation; 2006 Jul; 82(1):62-8. PubMed ID: 16861943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alemtuzumab induction in deceased donor kidney transplantation.
    Huang E; Cho YW; Hayashi R; Bunnapradist S
    Transplantation; 2007 Oct; 84(7):821-8. PubMed ID: 17984833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strategies to prevent chronic allograft nephropathy in kidney transplantation: focus on calcineurin inhibitors.
    Lo A
    Prog Transplant; 2004 Jun; 14(2):157-64. PubMed ID: 15264460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current status of immunosuppressive agents for solid organ transplantation in children.
    Coelho T; Tredger M; Dhawan A
    Pediatr Transplant; 2012 Mar; 16(2):106-22. PubMed ID: 22360399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcineurin-inhibitor minimization protocols in heart transplantation.
    Zuckermann AO; Aliabadi AZ
    Transpl Int; 2009 Jan; 22(1):78-89. PubMed ID: 18954366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Posttransplant diabetes mellitus in kidney transplant recipients receiving calcineurin or mTOR inhibitor drugs.
    Araki M; Flechner SM; Ismail HR; Flechner LM; Zhou L; Derweesh IH; Goldfarb D; Modlin C; Novick AC; Faiman C
    Transplantation; 2006 Feb; 81(3):335-41. PubMed ID: 16477217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inferior results with basis immunosuppression with sirolimus in kidney transplantation.
    van den Akker JM; Hené RJ; Hoitsma AJ
    Neth J Med; 2007 Jan; 65(1):23-8. PubMed ID: 17293636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current immunosuppressive agents in pediatric renal transplantation: efficacy, side-effects and utilization.
    Smith JM; Nemeth TL; McDonald RA
    Pediatr Transplant; 2004 Oct; 8(5):445-53. PubMed ID: 15367279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized long-term trial of tacrolimus and sirolimus versus tacrolimus and mycophenolate mofetil versus cyclosporine (NEORAL) and sirolimus in renal transplantation. I. Drug interactions and rejection at one year.
    Ciancio G; Burke GW; Gaynor JJ; Mattiazzi A; Roth D; Kupin W; Nicolas M; Ruiz P; Rosen A; Miller J
    Transplantation; 2004 Jan; 77(2):244-51. PubMed ID: 14742989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Toward an evidence-based immunosuppression].
    Pascual J
    Nefrologia; 2001; 21(6):524-5; discussion 526-7. PubMed ID: 11881421
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunosuppression for lung transplantation: evidence to date.
    Snell GI; Westall GP
    Drugs; 2007; 67(11):1531-9. PubMed ID: 17661526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends in adult post-kidney transplant immunosuppressive use in Australia, 1991-2005.
    Chang SH; Russ GR; Chadban SJ; Campbell S; McDonald SP
    Nephrology (Carlton); 2008 Apr; 13(2):171-6. PubMed ID: 18275507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.